DE238162C - - Google Patents
Info
- Publication number
- DE238162C DE238162C DE1908238162D DE238162DA DE238162C DE 238162 C DE238162 C DE 238162C DE 1908238162 D DE1908238162 D DE 1908238162D DE 238162D A DE238162D A DE 238162DA DE 238162 C DE238162 C DE 238162C
- Authority
- DE
- Germany
- Prior art keywords
- blood
- immune
- substances
- blood cells
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000126 substance Substances 0.000 claims description 20
- 210000000601 blood cell Anatomy 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 201000008827 tuberculosis Diseases 0.000 description 3
- 206010024229 Leprosy Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 210000004201 immune sera Anatomy 0.000 description 1
- 229940042743 immune sera Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT54778D AT54778B (de) | 1908-03-24 | 1909-03-24 | Verfahren zur Gewinnung von Immunstoffen. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE238162C true DE238162C (en, 2012) |
Family
ID=497711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1908238162D Expired - Lifetime DE238162C (en, 2012) | 1908-03-24 | 1908-03-24 |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE238162C (en, 2012) |
-
1908
- 1908-03-24 DE DE1908238162D patent/DE238162C/de not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3021006A1 (de) | Neues oberflaechenaktives material, verfahren zur herstellung desselben und dieses material enthaltendes pharmazeutisches mittel gegen hyalin-membran-erkrankung | |
| DE1720120A1 (de) | Injizierbare Zusatzmittel,Verfahren ihrer Herstellung und Verwendung und neue medizinische Zusammensetzungen,die dieses Zusatzmittel enthalten | |
| DE2735411A1 (de) | Verfahren zur herstellung von acellulaeren vaccinen und nach diesem verfahren gewonnene vaccine | |
| DE1195905B (de) | Verfahren zum Abtrennen der Zellwaende von Mycobacterium phlei | |
| DE2010788A1 (de) | Wasserunlösliche Substanzen mit Antigenwirkung und Verfahren zu ihrer Herstellung | |
| DE69209335T2 (de) | Mittel zur Zersetzung von Gallensteinen | |
| DE238162C (en, 2012) | ||
| DE1767196A1 (de) | Loesliche Krebsantigene,die an Fremdproteine gebunden sind | |
| AT54778B (de) | Verfahren zur Gewinnung von Immunstoffen. | |
| DE1818054C2 (de) | Verfahren zur Gewinnung von cytobiotischen Globulinen | |
| DE960579C (de) | Verfahren zur Herstellung eines in der Hitze sterilisierbaren Adrenocorticotropin-Praeparates | |
| DE2015804A1 (de) | Verfahren zur Herstellung eines antigenen oder allergenen Extraktes | |
| DE397551C (de) | Verfahren zur Gewinnung spezifischer Impfstoffe | |
| DE2713680A1 (de) | Verfahren zur herstellung eines mittels mit mitogenen und/oder adjuvans-eigenschaften und dieses mittel enthaltende arzneimittel | |
| CH652028A5 (de) | Extrakt aus pflanzen vom genus epimedium sp., verfahren zur herstellung dieses extrakts und verwendung des extrakts als wirksame komponente in einem immunstimulierenden mittel. | |
| DE2420706C3 (de) | Verfahren zum Herstellen von spezifischen Antigenen aus Schistosomen und jene enthaltendes Mittel | |
| DE128419C (en, 2012) | ||
| DE711720C (de) | Verfahren zur Anreicherung und Gewinnung eines die Steigerung der Leukocytenbildung bewirkenden Stoffes | |
| DE1617605A1 (de) | Antigenherstellung und Vakzine | |
| DE2245826C3 (de) | Salze von N-Cyano-äthyl-N'-m-chlorphenyl-piperazin | |
| DE707028C (de) | Verfahren zur Herstellung eines antithyreoidalen Stoffes | |
| DE68917830T2 (de) | Verfahren zur Herstellung einer physiologisch aktiven Substanz mit Antikrebs-Aktivität und so erhaltene Substanz. | |
| DE1000963C2 (de) | Verfahren zur Herstellung von biologisch aktiven, Vitamine der B-Gruppe enthaltenden Zubereitungen | |
| DE756640C (de) | Verfahren zur Herstellung von eiweissarmer Kautschukmilch oder Kautschuk daraus | |
| DE2110436B2 (de) | Verfahren zur Herstellung eines antileukopenischen und antikörperbildenden Thymusextrakts aus Kalbsthymus |